| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Laing Lance G. | Chief Science Officer, Director | 16305 36TH AVE N, SUITE 100, MINNEAPOLIS | /s/ Griffin D. Foster as Attorney-in-Fact for Lance G. Laing | 20 Aug 2025 | 0001716041 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CELC | Stock Option (right to buy) | Award | $0 | +100K | $0.00 | 100K | 18 Aug 2025 | Common Stock | 100K | $51.57 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | 25,000 shares vest on 8/18/2026; the remaining 75,000 shares vest 1/36th per month thereafter. |